Question Bank › Order-of-magnitude gap

Order-of-magnitude gap

Order-of-magnitude gap: the company is already serving a demand source whose scale dwarfs its own current business

Calls Tested
489
Answered YES
13
Hit Rate
2.7%
rare by design

Cross Country Healthcare, Inc. (CCRN) — this company's answers

NO on the Q1 2022 call 2022-05-04 B
The model's full reasoning — Q1 2022 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了公司规模与已服务需求之间的不匹配。关键点:公司是否已经处于一个巨大的活动流中,且管理层明确指出了这种规模差异。 在记录中,管理层提到: - 收入增长140%,达到7.89亿美元,创历史新高。 - 在岗专业人员数量增长超过100%。 - 管理服务项目(MSP)的年化支出超过20亿美元,捕获率约70%。 - 需求仍比疫情前高30%以上。 - 公司预计退出年化收入超过20亿美元。 但问题在于:管理层是否明确指出了公司当前规模与所服务巨大市场之间的不匹配?他们提到MSP支出20亿美元,但公司收入7.89亿美元(季度),年化约30亿美元?实际上,20亿美元是年化支出,而公司季度收入7.89亿,年化约31.5亿,所以公司已经大于20亿?不,20亿是MSP的支出,公司捕获70%,即约14亿?但公司总收入包括其他业务。实际上,管理层说“spend under management for the first quarter was over $2 billion on an annualized basis for the capture rate of approximately 70%”,即年化支出20亿,捕获70%即14亿,但公司季度收入7.89亿,年化31.5亿,所以公司收入大于MSP支出?可能MSP只是部分业务。但管理层没有明确说“我们只占了这个市场的很小一部分”之类的。 管理层提到“demand remains well ahead of the prior year, though down from the peak”,但未明确对比公司规模与市场总量。他们提到“we expect to exit the year on a run-rate that exceeds $2 billion in annualized revenue”,但这是公司自身目标,不是市场对比。 关键:管理层是否明确指出了公司当前规模与所服务巨大市场之间的不匹配?例如,他们是否说“我们只捕获了市场的X%”?没有。他们提到MSP捕获率70%,但那是他们自己的捕获率,不是市场份额。他们提到“spend under management”是20亿,但公司收入更大,所以不构成“巨大相对”。 另外,他们提到“demand is still up over 30% from pre-pandemic level”,但那是需求增长,不是市场规模对比。 因此,没有明确的不匹配描述。管理层只是报告了强劲增长和需求,但没有说“我们只占了这个巨大市场的很小一部分”之类的。 所以答案应为NO。

← Back to the full CCRN analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe a MISMATCH OF SCALE between the company and the demand it is already serving — that is, does management convey that the company is currently supplying, serving, or participating in something whose size, spending, volume, or population is ENORMOUS RELATIVE TO THE COMPANY'S OWN CURRENT BUSINESS, such that even a modest further share of it would make the company several times bigger than it is today? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation with BOTH of the following present: (1) THE COMPANY IS ALREADY INSIDE IT, WITH REAL BUSINESS TO POINT TO. Management describes actual, present-tense participation — orders being filled, customers being served, product shipping, work being performed, activity running now — in something identifiable and much larger than the company: a large counterparty's or industry's ongoing spending, build-out, program, or platform; a population, installed base, fleet, or footprint the company is already qualified and selling into; a category of use, market, or channel where the company's offering is already being bought. Real current activity is required — not a pipeline, not a bid outstanding, not an approval pending, not a market the company hopes to enter. (2) MANAGEMENT ITSELF DRAWS THE SIZE CONTRAST, AND TREATS IT AS THE POINT. Management makes the disproportion explicit or unmistakable in substance — for example by noting how small a fraction of the available activity, spend, sites, accounts, or units it has captured so far; by comparing a single customer, contract, program, or location's potential against the whole company's current size; by describing how much larger the thing it serves is than what the company currently earns from it; or by explaining that its own results to date reflect only the earliest sliver of what it is already positioned inside. Management should treat this gap between its present size and the scale of what it already touches as a central fact about the company, not as a passing remark, and should ground it in the concrete activity described rather than in an abstract market-size figure. The essence is ONE phenomenon: a small business standing inside a very large flow of activity that is already reaching it, where the binding question is how much of that flow it captures rather than whether the flow exists. The industry, the nature of the large flow, and the form of the company's participation may vary widely. Answer NO if the company is large relative to what it describes, or is already a leading participant with no meaningful multiple ahead of it. NO if the large opportunity is only prospective — a market not yet entered, an approval or decision still pending, a product still being developed, a customer still being pursued — rather than something the company is already inside and already earning from. NO if the only "big opportunity" language is a generic total-addressable-market number, an industry growth statistic, or promotional talk about a huge market, with no reference to how little of it this company has taken. NO if management merely reports strong demand, a good quarter, a large backlog, or a healthy pipeline without conveying the disproportion between the company's size and what it is already serving. NO if the disproportion is described only as a dependency risk or concentration concern management is trying to reduce. NO if the gap exists only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
CRGO Freightos Limited Q1 2024 2024-05-20 C+
WRBY Warby Parker Inc. Q1 2024 2024-05-09 A
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
GDRX GoodRx Holdings, Inc. Q2 2022 2022-08-08 F
FLYW Flywire Corporation Q1 2022 2022-05-14 B+
IRTC iRhythm Technologies, Inc. Q1 2022 2022-05-07 C+
HROW Harrow Health, Inc. Q4 2021 2022-03-10 C
RELY Remitly Global, Inc. Q4 2021 2022-03-02 B
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
HSTM HealthStream, Inc. Q3 2017 2017-10-24 C

How the model reasoned

HROW · Q4 2021 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript shows management describing Harrow as already inside the large cataract surgery market (4.5–6 million procedures annually) with real, present-tense participation: thousands of customer relationships, shipping north of two million sterile ophthalmic units last year, and touching roughly one million cataract surgeries. They explicitly contrast this scale against 2021 revenues of $72.5 million, noting that even a modest share of the pass-through-eligible market (1 million procedures × premium pricing) would produce “a big number” and drive revenues “more than double” in the near term. They treat the current business as only the “earliest sliver” of what they are already positioned inside, with the binding question being how much of the existing flow they can capture rather than whether the flow exists. This meets both criteria. The answer is YES. The transcript shows management describing Harrow as already inside the large cataract surgery market (4.
WRBY · Q1 2024 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript explicitly states that the company is already inside the optical industry with real business (245 stores serving customers, 83% of stores offering exams, 2.36 million active customers, and growing revenue from glasses, contacts, and exams). Management then draws the size contrast directly, noting that even the longer 900-store target "would still represent a small fraction of the 45,000 optical shops in the U.S." and that over 50% of major metro areas have only one store.
HSTM · Q3 2017 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...**YES** Management describes the company already being inside a much larger flow of activity (the 80 million-person healthcare workforce, of which 4.6 million are in post-acute settings) and explicitly treats the scale mismatch as the central point. They note their strong sales team is already a “steady contributor” to 4.

More from the question bank

Fresh change already executed, benefit mostlUpside surprise with durable, still-buildingStrong facts, held-back storyRunning ahead of their own plan — and manageThe company itself is the constraintReady-to-run scale already paid for and now All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.